50 employees
FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases.
2012
$5.3M
from 2 investors over 2 rounds
FF Pharmaceuticals BV raised $5.3M on January 23, 2013
Investors: PMV Pharmaceuticals, Inc. and Vesalius Biocapital